Delegates from MIP International Patent Forum 2019 included delegates from:
4D Pharma Aalbun ABBYY AGCO Airbus Defence and Space Aistemos Altius Amadeus Intellectual Property Amdocs Anand & Anand ARM Avalue AWA Barclays Benchmark Holdings BenevolentAI Bharucha & Co Boston Consulting Group Boult Wade Tennant BP International Bracco Bristows British American Tobacco BT Business Atrium Canon Europe Cell and Gene Therapy Catapult Centrica Cermak a spol. Chadha & Chadha Charles Russell Speechlys ClearViewIP Delegate Dennemeyer Deris Attorneys-at-Law Elekta Ericsson European Patent Office Finnegan Henderson Farabow Garrett & Dunner Five AI Fresenius Kabi GBG GE International GKN Automotive GlaxoSmithKline Gordon Murray Design Gorodissky Gowling WLG GPI & Associes Green Biologics GSK Gün + Partners Huawei Insud Pharma Intellectual Ventures IP Academy of Singapore ipan delegate Iqvia J. E. Dias Costa Kaneka Kirkland & Ellis KPN Krishna & Saurastri Associates Leukocare Licks Attorneys Mars Chocolate UK Maucher Jenkins Meissner Bolte Minesoft Ministry of Defence Mitsubishi Heavy Industries Europe Moroğlu Arseven Nanoporetech Nokia Novartis Novozymes NXP Semiconductors Ocado Owen Mumford Patentsight PAVIS Premier Foods Queen Mary University of London Questel RB Regeneron Pharmaceuticals Renishaw Rouse Science and Technology Facilities Council Shell International Sisvel Smiths Detection Sudatel Synthomer Tate & Lyle Teledyne e2v Thyssenkrupp Tivo TransPerfect TWI Uber UCB UK Intellectual Property Office Unilever University College London University of Cambridge University of Reading University of Sussex Valea Vocalink Vodafone Group Wildanger Rechtsanwälte Yara Zentiva Zuykov and partners
July /August 2019
AI and IP: the view from above
Managing IP speaks to the directors of WIPO and the EUIPO to gauge their views on AI, asking how the technology can help the offices be more efficient and whether job losses are inevitable
The material on this site is for financial institutions, professional investors
and their professional advisers. It is for information only. Please read our
Terms and Conditions
before using the site. All material subject to strictly enforced copyright laws.
© 2019 Euromoney Institutional Investor PLC. For help please
see our FAQ.
Switching to MIP International